GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity
Hilal Simsek, Asli Ucar · 2026
Read GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity by Hilal Simsek, Asli Ucar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272609.txt.
Description
Hilal Simsek and Asli Ucar wrote a 2026 scoping review on weight-loss drugs called GLP-1 receptor agonists in older adults with obesity. These drugs aid weight loss, but lost weight can include muscle. That matters because low muscle mass and strength, called sarcopenia, can combine with obesity in older people.
The review finds that muscle loss is common with these drugs, and data on muscle size and strength are still thin and mixed. Some signs point to better muscle metabolism and less inflammation. The authors advise pairing the drugs with strength exercise, diet advice, and protein at 1.2 to 1.6 grams per kilogram per day.
Catalog record
| CREATOR | Hilal Simsek, Asli Ucar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48959 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |